Eshelman Ventures

Summary

The main office of represented VC is situated in the Wilmington. The fund was located in North America if to be more exact in United States.

Among the most popular portfolio startups of the fund, we may highlight Dignify Therapeutics, Sapience Therapeutics, Sapience Therapeutics. The fund has no exact preference in a number of founders of portfolio startups. When startup sums 3 or 4 of the founder, the probability for it to get the investment is little. For fund there is a match between the location of its establishment and the land of its numerous investments - United States. Besides, a startup needs to be aged 4-5 years to get the investment from the fund. We can highlight the next thriving fund investment areas, such as Developer Platform, Biotechnology.

The typical case for the fund is to invest in rounds with 4-5 participants. Despite the Eshelman Ventures, startups are often financed by Mountain Group Capital, MedImmune Ventures, Hatteras Venture Partners. The meaningful sponsors for the fund in investment in the same round are RA Capital Management, TaiAn Technologies, Mountain Group Capital. In the next rounds fund is usually obtained by Tavistock Life Sciences, TaiAn Technologies, Small Business Innovation Research.

This organization was formed by Fred Eshelman.

Considering the real fund results, this VC is 51 percentage points more often commits exit comparing to other organizations. Comparing to the other companies, this Eshelman Ventures performs on 15 percentage points less the average number of lead investments. The higher amount of exits for fund were in 2017. When the investment is from Eshelman Ventures the average startup value is 10-50 millions dollars. The important activity for fund was in 2015. Despite it in 2019 the fund had an activity. Deals in the range of 10 - 50 millions dollars are the general things for fund. The fund is generally included in less than 2 deals every year.